Breast cancer

Breast carcinoma is the most common tumor in the female population, with the risk increasing progressively with age. There is also breast cancer in men. 

It is caused by uncontrolled multiplication of the cells of the mammary gland, which transform into malignant cells. 

Among the many contributing factors, environmental factors and lifestyle choices play a role alongside individual genetic predispositions. 

The treatment pathway for breast cancer is determined by the medical team based on tumor size, involvement of regional lymph nodes, tumor biology, stage, age, and the patient's overall condition. 

For early-stage tumors, possible treatments include breast surgery, radiotherapy, and medical oncological treatments (hormone therapies, chemotherapies, immunotherapy and targeted molecular drugs). 

For metastatic tumors, treatments are generally of an oncological medical nature (hormone therapies, chemotherapies, immunotherapy, targeted molecular drugs), often combined with radiotherapy and palliative therapies. At this stage, surgery is reserved for specific indications evaluated by the medical team in consultation with the patient. 

At this institution, breast carcinoma management relies heavily on a multidisciplinary approach involving all professionals involved in the care pathway, with the aim of personalizing and optimizing the sequence and coordination of the various indicated treatments.